The Future of PTSD Treatment Is Already Here. Why Can’t Veterans Access It?

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to basket failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Unfollow podcast failed

The Future of PTSD Treatment Is Already Here. Why Can’t Veterans Access It?

Listen for free

View show details

In the final episode of our PTSD series, Scott speaks with Dr. Jessica Maples Keller of Emory University about the future of psychedelic-assisted therapy for PTSD.Emory has been studying MDMA and psilocybin in a clinical setting, with a focus on how these treatments might enhance evidence-based care like prolonged exposure therapy. Dr. Maples Keller explains how clinical trials are designed, why Schedule I status creates major barriers, what safety screening looks like, and why access and cost may become the next major challenge even if psychedelic-assisted treatments are eventually approved.Then LTG(R) Walt Piatt, CEO of Wounded Warrior Project, returns to close out the series. He reflects on where the veteran community stands in addressing PTSD, what the VA and DoD are getting right and wrong, and whether the innovation happening across nonprofits, universities, and private organizations is a hopeful story about American civil society — or a sign that government systems are still moving too slowly.This episode asks a simple question: if the future of PTSD treatment is already being built, why are so many veterans still waiting?Guests:Dr. Jessica Maples Keller — Associate Professor, Emory University School of MedicineLTG(R) Walt Piatt — CEO, Wounded Warrior ProjectResources:Emory Healthcare Veterans Program:https://www.emoryhealthcare.org/centers-programs/veterans-programFor information about Emory psychedelic-assisted therapy studies:PATstudy@emory.eduMAPS — Multidisciplinary Association for Psychedelic Studies:https://maps.org/STRONG STAR:https://www.strongstar.org/Compass Pathways:https://compasspathways.com/Heroic Hearts Project:https://heroicheartsproject.org/Oregon Psilocybin Services:https://www.oregon.gov/psilocybinAustralia Therapeutic Goods Administration — MDMA and psilocybin:https://www.tga.gov.au/products/unapproved-therapeutic-goods/mdma-and-psilocybineWounded Warrior Project:https://www.woundedwarriorproject.org/

No reviews yet